Search by Drug Name or NDC

    NDC 68001-0480-22 Irinotecan hydrochloide 20 mg/mL Details

    Irinotecan hydrochloide 20 mg/mL

    Irinotecan hydrochloide is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is IRINOTECAN HYDROCHLORIDE.

    Product Information

    NDC 68001-0480
    Product ID 68001-480_0904e574-8e86-f26a-e063-6394a90afc0b
    Associated GPIs 21550040102030 21550040102025
    GCN Sequence Number 062174
    GCN Sequence Number Description irinotecan HCl VIAL 100 MG/5ML INTRAVEN
    HIC3 V3E
    HIC3 Description ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS
    GCN 97956
    HICL Sequence Number 010778
    HICL Sequence Number Description IRINOTECAN HCL
    Brand/Generic Generic
    Proprietary Name Irinotecan hydrochloide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Irinotecan hydrochloide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name IRINOTECAN HYDROCHLORIDE
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212993
    Listing Certified Through 2024-12-31

    Package

    NDC 68001-0480-22 (68001048022)

    NDC Package Code 68001-480-22
    Billing NDC 68001048022
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480-22) / 5 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2020-12-14
    NDC Exclude Flag N
    Pricing Information N/A